Research & Development
Researchers engineer bacterial biosensor that can detect tumor DNA
The technique, dubbed Cellular Assay for Targeted CRISPR-discriminated Horizontal gene transfer and known by the acronym CATCH, was designed to identify specific DNA sequences and mutations outside of cells.
August 14, 2023
Exact Sciences raises full-year guidance due to demand for colorectal cancer test
Revenues for Exact Sciences’ screening business, which sells the Cologuard colorectal cancer stool test, increased by 31% to $462.8 million in the second quarter.
August 10, 2023
New Day Diagnostics inks $12M deal to buy Epigenomics’ cancer technology
Epigenomics has agreed to sell “substantially all” of its assets to New Day Diagnostics, a developer of tests for the early detection and monitoring of disease that merged with EDP Biotech earlier this month.
July 31, 2023
Harvard Medical School, RareCyte developing multiplex imaging for clinical pathology
Multiplex imaging technology enables the integration of microscopic analysis with the visualization of molecular markers in individual cells.
June 26, 2023
Next-gen Cologuard demonstrates 94% sensitivity, 91% specificity for colorectal cancer detection
The firm also entered collaborations related to next-generation technology for ultra-sensitive detection of molecular residual disease (MRD) and ongoing research, as well as for the development of its multicancer early detection (MCED) approach.
June 21, 2023
Colorectal cancer growth and chemoresistance linked to specific protein in study
Colorectal cancer grows faster and becomes more resistant to common chemotherapy drugs when elevated levels of a specific protein are present.
June 16, 2023
Genetic counseling may boost colorectal cancer patient empowerment: Study
A randomized controlled genetic counseling trial for those affected by colorectal cancer showed significant improvements in patient empowerment.
June 12, 2023
Polygenic risk scores may improve colorectal cancer screening
Polygenic risk scores may identify individuals at high risk of developing colorectal cancer, improving current screening strategies for the disease.
June 12, 2023
Bacteria vary between early- and late-onset colorectal cancer tumors: Study
Bacteria types vary widely between early- versus late-onset colorectal cancer tumors, providing clues to the disease’s increase in younger people, according to a study.
May 30, 2023
Biocartis, HiloProbe collaborating to commercialize, distribute colorectal cancer gene-expression test
The test, ColoNode, is CE-marked and will be distributed first as a manual kit by Biocartis to expert laboratories in selected European countries.
May 9, 2023
Exact Sciences shares rise on 24% Q1 revenue growth, higher 2023 guidance
The firm is seeing a “dramatic increase in the electronic ordering rate” at health systems, which is helping grow sales, its CEO Kevin Conroy said.
May 10, 2023
Red flags signal early-onset colorectal cancer
Recognizing four red flags for early-onset colorectal cancer may be key to earlier detection, diagnosis, and improved survival among younger patients.
May 5, 2023
Page 1 of 6